These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36815381)

  • 21. Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation.
    Koch K; Richter J; Hanel C; Huttmann A; Duhrsen U; Klapper W
    Haematologica; 2022 Sep; 107(9):2144-2153. PubMed ID: 35021600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary parenchymal CNS involvement by lymphoma including rare types: Follicular and EBV-positive NK/T cell lymphoma, nasal type.
    Kleinschmidt-DeMasters BK; Gilani A
    Ann Diagn Pathol; 2021 Aug; 53():151765. PubMed ID: 34147846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
    Muntañola A; Mozas P; Mercadal S; Huguet M; Bobillo S; Bastos-Oreiro M; Jiménez-Ubieto A; Rovira J; Rivero A; Tolosa C; Luizaga L; de Villambrosia SG; Novelli S; Caballero D; Salar A; Alonso-Álvarez S; Magnano L; Gutiérrez NC; Sancho JM; López-Guillermo A;
    Br J Haematol; 2023 Feb; 200(3):306-314. PubMed ID: 36261137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.
    Sarkozy C; Trneny M; Xerri L; Wickham N; Feugier P; Leppa S; Brice P; Soubeyran P; Gomes Da Silva M; Mounier C; Offner F; Dupuis J; Caballero D; Canioni D; Paula M; Delarue R; Zachee P; Seymour J; Salles G; Tilly H
    J Clin Oncol; 2016 Aug; 34(22):2575-82. PubMed ID: 27298402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
    Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
    Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B-cell lymphoma.
    Herrera AF; Goy A; Mehta A; Ramchandren R; Pagel JM; Svoboda J; Guan S; Hill JS; Kwei K; Liu EA; Phillips T
    Am J Hematol; 2020 Jan; 95(1):18-27. PubMed ID: 31621094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
    Tun AM; Maliske S; Wang Y; Inwards DJ; Habermann TM; Micallef I; Porrata L; Paludo J; Bisneto JV; Rosenthal A; Kharfan-Dabaja MA; Ansell SM; Nowakowski GS; Farooq U; Johnston PB
    Transplant Cell Ther; 2022 Sep; 28(9):610-617. PubMed ID: 35752441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma.
    Xue T; Yu BH; Yan WH; Jiang XN; Tian T; Zhou XY; Li XQ
    Hematol Oncol; 2020 Dec; 38(5):665-672. PubMed ID: 32627854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutions.
    Mercadal S; Sancho JM; Climent F; Tapia G; Pomares H; Carro I; Sorigué M; Pané M; Domingo-Doménech E; Encuentra M; Aguilera C; Oliveira AC; Andrade M; Fernández de Sevilla A; Ribera JM; González-Barca E; Sureda A
    Eur J Haematol; 2020 Mar; 104(3):198-206. PubMed ID: 31769545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma.
    Falchi L; Ferrajoli A; Jacobs I; Nava-Parada P
    Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):508-518.e14. PubMed ID: 29934061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical Features of Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma].
    Zhang XL; Yu WJ; Zhu YN; Yang CM; Xiao F; Mai WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1772-1778. PubMed ID: 36476902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological prognostic indicators in 107 patients with diffuse large B-cell lymphoma transformed from follicular lymphoma.
    Maeshima AM; Taniguchi H; Fukuhara S; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Cancer Sci; 2013 Jul; 104(7):952-7. PubMed ID: 23521357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy.
    Yuan J; Greiner TC; Fu K; Smith LM; Aoun P; Chan WC; Bierman PJ; Bociek RG; Vose JM; Armitage JO; Weisenburger DD
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):488-497.e2. PubMed ID: 28842137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
    Ren J; Asche CV; Shou Y; Galaznik A
    J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
    Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
    J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diffuse large B-cell lymphoma developed newly after 9-year remission of a follicular lymphoma].
    Hirano T; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Tsuda H
    Rinsho Ketsueki; 2016 Feb; 57(2):171-4. PubMed ID: 26935635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era.
    Nowakowski GS; Maurer MJ; Habermann TM; Ansell SM; Macon WR; Ristow KM; Allmer C; Slager SL; Witzig TE; Cerhan JR
    J Clin Oncol; 2010 Jan; 28(3):412-7. PubMed ID: 20008638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
    Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
    J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicular lymphoma grade 3: review and updates.
    Vaidyanathan G; Czuczman MS
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):431-5. PubMed ID: 25066038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.
    Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW
    Ann Oncol; 2015 Nov; 26(11):2311-7. PubMed ID: 26362568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.